Adapting Federal Regulatory Approaches To Advances In Agricultural Biotechnology by Sachs, Alan
University of Maryland Francis King Carey School of Law 
DigitalCommons@UM Carey Law 
Maryland Law Review Online 
2021 
Adapting Federal Regulatory Approaches To Advances In 
Agricultural Biotechnology 
Alan Sachs 
Follow this and additional works at: https://digitalcommons.law.umaryland.edu/endnotes 
 Part of the Agriculture Law Commons, and the Environmental Law Commons 
Recommended Citation 
The citation for the article is Alan J. Sachs, Adapting Federal Regulatory Approaches To Advances In 
Agricultural Biotechnology, 80 Md. L. Rev. Online 36 (2021) 
This Articles from Volume 80 is brought to you for free and open access by DigitalCommons@UM Carey Law. It has 
been accepted for inclusion in Maryland Law Review Online by an authorized administrator of 




ADAPTING FEDERAL REGULATORY APPROACHES TO 
ADVANCES IN AGRICULTURAL BIOTECHNOLOGY 
ALAN SACHS*  
Since it was first announced by the White House Office of Science and 
Technology Policy (“OSTP”) in 1986, the Coordinated Framework for the 
Regulation of Biotechnology (“Framework”) has sought to achieve 
“reasonable safeguards for the public” by regulating products of 
biotechnology across a network of agency jurisdictions using existing federal 
statutory authorities, as opposed to calling for the implementation of new 
legislation.1  Working to achieve a balance between appropriate health and 
environmental safety regulations while maintaining sufficient flexibility to 
“avoid impeding the growth” of what was considered an “infant industry” at 
the time, the Framework was built on a foundational determination that the 
existing mosaic of existing federal laws, as currently implemented, would for 
the most part “adequately” address regulatory needs.2   
One of the key challenges associated with formulating any federal 
approach to biotechnology regulation is the sheer diversity of products that 
can be developed with genetic engineering—including agricultural crops and 
livestock, pesticides, food, plants, human and animal drugs, and 
microorganisms with a range of industrial applications.  These products are 
already regulated by a myriad of agencies, meaning a unitary statutory 
approach addressing all products of biotechnology would be challenging.3  
More than three decades after the Framework was first announced—and 
notwithstanding periodic controversy,4 continued uneasiness with products 
of genetic engineering among sectors of the American public,5 as well as 
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 1. Coordinated Framework for Regulation of Biotechnology, 51 Fed. Reg. 23,302, 23,302 
(June 26, 1986). 
 2. Id. at 23,303.  
 3. Although a number of federal agencies are involved in regulating products of 
biotechnology, this discussion focuses on the Environmental Protection Agency (“EPA”), Food and 
Drug Administration (“FDA”), and U.S. Department of Agriculture (“USDA”). 
 4. See, e.g., Biotechnology, Genetic Engineering, and “GMOs:” Why all the Controversy?, 
INST. OF FOOD TECHNOLOGISTS (Sept. 12, 2018), https://www.ift.org/career-development/learn-
about-food-science/food-facts/food-facts-emerging-science-and-technologies/biotechnology-
genetic-engineering-gmos. 
 5. See CARY FUNK & BRIAN KENNEDY, THE NEW FOOD FIGHTS: U.S. PUBLIC DIVIDES OVER 
FOOD SCIENCE, PEW RESEARCH CENTER 46 (2016), https://www.pewresearch.org/internet/wp-
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groundbreaking advances in biotechnology that could hardly have been 
foreseen by the Framework’s authors in 1986—OSTP’s original decision to 
balance regulation and flexibility within existing statutory authorities has 
largely stood the test of time.  Contemporary agency efforts to adapt 
regulatory approaches to novel advances in agricultural biotechnology, while 
remaining true to the Framework’s decades-old intent and design, bear this 
out. 
The Framework originally sought to cover the full spectrum of 
biotechnology applications by assigning jurisdiction over the commercial 
end-products of biotechnology based on each agency’s experience with the 
review and regulation of similar products developed using conventional 
techniques.  For example, the U.S. Department of Agriculture (“USDA”) 
would be responsible for genetically engineered animal biologics, plant pests, 
seeds, animal pathogens, and meat, poultry, and eggs;6 the U.S. 
Environmental Protection Agency (“EPA”) was tasked with responsibility 
over genetically engineered microbial pesticides and intergeneric 
microorganisms;7 and the U.S. Food and Drug Administration (“FDA”) was 
assigned oversight for genetically engineered foods, food additives, human 
drugs, biologics and devices, and animal drugs.8  In developing their 
coordinated but specific biotechnology regulatory programs, each agency 
was able to rely on authorities prescribed by an array of existing 
environmental laws and other statutes, including the Federal Plant Pest Act 
(superseded in 2000 by the Plant Protection Act (“PPA”));9 the Federal Seed 
Act (“FSA”);10 the Federal Insecticide, Fungicide, and Rodenticide Act 
(“FIFRA”);11 the Federal Food, Drug, and Cosmetic Act (“FFDCA”);12 the 
                                                          
content/uploads/sites/9/2016/11/PS_2016.12.01_Food-Science_FINAL.pdf (finding that 39% of 
Americans believe genetically modified food is harmful to consume). 
 6. USDA’s Role, UNIFIED WEBSITE FOR BIOTECHNOLOGY REGUL., 
https://usbiotechnologyregulation.mrp.usda.gov/biotechnologygov/about (last visited Feb. 11, 
2021). 
 7. EPA’s Role, UNIFIED WEBSITE FOR BIOTECHNOLOGY REGUL., 
https://usbiotechnologyregulation.mrp.usda.gov/biotechnologygov/about (last visited Feb. 11, 
2021). 
 8. FDA’s Role, UNIFIED WEBSITE FOR BIOTECHNOLOGY REGUL., 
https://usbiotechnologyregulation.mrp.usda.gov/biotechnologygov/about (last visited Feb. 11, 
2021). 
 9. Federal Plant Pest Act, Pub. L. No. 85-36, 71 Stat. 31 (1957), repealed by Agriculture Risk 
Protection Act of 2000, Pub. L. No. 106-224, 114 Stat. 358. 
 10. Federal Seed Act, 7 U.S.C. §§ 1551–1611. 
 11. Federal Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. §§ 136–136y. 
 12. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §§ 301–399i. 
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Toxic Substances Control Act (“TSCA”);13 the Federal Meat Inspection Act 
(“FMIA”);14 and the Poultry Products Inspection Act (“PPIA”).15   
In 1992, OSTP released an update to the Framework reaffirming that 
federal oversight “focuses on the characteristics of the biotechnology product 
and the environment into which it is being introduced, not the process by 
which the product is created” and clarifying that the “[e]xercise of oversight 
in the scope of discretion afforded by statute should be based on the risk 
posed by the introduction and should not turn on the fact that [a 
biotechnology product] has been modified by a particular process or 
technique.”16  OSTP’s continued emphasis on the evaluation of each end-
product of agricultural biotechnology, irrespective of the genetic engineering 
process used in its development, has proved remarkably resilient even as 
scientific advancements over the last thirty years have progressed from 
introducing recombinant DNA (“rDNA”) molecules through almost 
exclusive reliance on bacterial vectors (frequently plant pest organisms 
themselves) to, within just the last few years, the widespread use of 
revolutionary genome editing techniques like Clustered Regularly 
Interspaced Short Palindromic Repeats (“CRISPR”) that allow developers to 
target specific genome mutations by inserting, deleting, or modifying DNA 
in living organisms.17   
In 2017, OSTP published a second update to the Framework.  While 
concluding that the current federal regulatory system for the products of 
biotechnology “effectively protects health and the environment,” OSTP also 
observed that certain unnecessary costs and burdens associated with 
uncertainty about agency jurisdiction, lack of predictability of timeframes for 
review, and other processes limit the ability of technology developers to 
successfully navigate the regulatory process.18  The 2017 update also 
acknowledged that regulatory complexities hamper the public’s ability to 
easily understand how the safety of these products is assured.19   
Consistent with a number of key recommendations expressed in the 
2017 update, federal agencies have undertaken significant actions in recent 
                                                          
 13. Toxic Substances Control Act, 15 U.S.C. §§ 2601–2629. 
 14. Federal Meat Inspection Act, 21 U.S.C. §§ 601–695. 
 15. Poultry Products Inspection Act, 21 U.S.C. §§ 451–472. 
 16. Exercise of Federal Oversight Within Scope of Statutory Authority: Planned Introductions 
of Biotechnology Products Into the Environment, 57 Fed. Reg. 6753, 6753 (Feb. 27, 1992). 
 17. What is CRISPR?, JACKSON LAB’Y, https://www.jax.org/personalized-medicine/precision-
medicine-and-you/what-is-crispr# (last visited Feb. 12, 2021). 
 18. OFF. OF SCI. & TECH. POL’Y, WHITE HOUSE, MODERNIZING THE REGULATORY SYSTEM 
FOR BIOTECHNOLOGY PRODUCTS: FINAL VERSION OF THE 2017 UPDATE TO THE COORDINATED 
FRAMEWORK FOR THE REGULATION OF BIOTECHNOLOGY 1, 5 (2017), 
https://www.epa.gov/sites/production/files/2017-
01/documents/2017_coordinated_framework_update.pdf.  
 19. Id.  
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years to clarify their respective roles, processes, and procedures under the 
Framework.  These efforts have included USDA’s statement that it does not 
regulate plants developed with genome-editing techniques (as long as they 
are developed without the use of a plant pest as the donor or vector, and they 
are not themselves plant pests);20 and FDA’s commitment to develop 
guidance explaining how its current regulatory policy for foods derived from 
new plant varieties applies to foods produced using genome editing.21  In 
May 2020, USDA established comprehensive new regulations, known as the 
“SECURE rule,” that represent an overhaul of longstanding regulatory 
requirements for genetically engineered organisms that pose plant pest 
risks.22   
Efforts sparked by the 2017 update are ongoing.  Recently, EPA 
proposed new regulations to exempt certain plant-produced substances 
developed using biotechnology (known as “plant-incorporated protectants,” 
or “PIPs”) from FIFRA and FFDCA requirements if those substances are 
otherwise found in plants that are sexually compatible with the recipient plant 
and meet certain other criteria.23  Additional initiatives, such as EPA, FDA, 
and USDA’s joint publication of a new “Unified Website for Biotechnology 
Regulation,” reflect broader federal efforts to improve transparency and 
reduce uncertainty for the regulated community and the wider American 
public.24   
Although science never remains static and future advances in genetic 
engineering will undoubtedly press agricultural biotechnology techniques to 
ever-expanding frontiers, agency regulations are necessarily framed around 
an understanding of commercially viable techniques in existence at a 
particular moment in time.  Even so, the Framework’s regulation-by-product 
approach has, for over thirty years, provided federal agencies with flexibility 
to adapt their respective regulatory programs under existing environmental 
statutory authorities to address scientific innovations as well as ongoing 
developments in the understanding of potential risks.   
                                                          
 20. Press Release, U.S. Dep’t of Agric., Secretary Perdue Issues USDA Statement on Plant 
Breeding Innovation (Mar. 28, 2017), https://www.usda.gov/media/press-
releases/2018/03/28/secretary-perdue-issues-usda-statement-plant-breeding-innovation.  
 21. U.S. FOOD & DRUG ADMIN., PLANT AND ANIMAL BIOTECHNOLOGY INNOVATION ACTION 
PLAN 1–3 (2018), https://www.fda.gov/media/119882/download.  
 22. Movement of Certain Genetically Engineered Organisms, 85 Fed. Reg. 29,790, 29,791 n.3 
(May 18, 2020) (codified at 7 C.F.R. pt. 330, 340, 372). 
 23. Pesticides; Exemptions of Certain Plant-Incorporated Protectants (PIPs) Derived From 
Newer Technologies, 85 Fed. Reg. 64,308, 64,308 (proposed Oct. 9, 2020) (to be codified at 40 
C.F.R. pt. 174). 
 24. About the Coordinated Framework, UNIFIED WEBSITE FOR BIOTECHNOLOGY REGUL., 
https://usbiotechnologyregulation.mrp.usda.gov/biotechnologygov/about (last visited Feb. 12, 
2021). 
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Operating within the Framework, regulatory agencies have the ability to 
continuously reinforce their commitments to regulatory certainty and health 
and environmental safety, all of which are necessary to support industry 
innovation and consumer confidence in biotechnology-derived products.  
Looking ahead, there may be growing importance attached to this 
fundamental aspect of the Framework’s approach, which encourages regular 
review and, as appropriate, updating agency policies and requirements to 
adapt to advances in biotechnology and management of associated risks. 
 
